Ocular Therapeutix (OCUL) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to -$65.2 million.
- Ocular Therapeutix's Income towards Parent Company fell 3313.13% to -$65.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$263.5 million, marking a year-over-year decrease of 5962.16%. This contributed to the annual value of -$263.5 million for FY2025, which is 5962.16% down from last year.
- According to the latest figures from Q4 2025, Ocular Therapeutix's Income towards Parent Company is -$65.2 million, which was down 3313.13% from -$68.0 million recorded in Q3 2025.
- Over the past 5 years, Ocular Therapeutix's Income towards Parent Company peaked at -$19.5 million during Q1 2022, and registered a low of -$68.0 million during Q3 2025.
- Its 5-year average for Income towards Parent Company is -$34.4 million, with a median of -$22.9 million in 2022.
- Per our database at Business Quant, Ocular Therapeutix's Income towards Parent Company soared by 1094.77% in 2022 and then crashed by 11550.88% in 2024.
- Over the past 5 years, Ocular Therapeutix's Income towards Parent Company (Quarter) stood at -$19.7 million in 2021, then fell by 5.38% to -$20.8 million in 2022, then dropped by 9.42% to -$22.7 million in 2023, then crashed by 115.51% to -$49.0 million in 2024, then plummeted by 33.13% to -$65.2 million in 2025.
- Its Income towards Parent Company was -$65.2 million in Q4 2025, compared to -$68.0 million in Q3 2025 and -$67.2 million in Q2 2025.